Sign in

CIK 0001367083

  • Non-accelerated filer
  • Smaller reporting company

Sonoma Pharmaceuticals, Inc.

Sign in to watch
Ticker
SNOA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
680423298
Phone
+1 800-759-9305
Business address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
Former names
Oculus Innovative Sciences, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  5. 4 Open-market sale Chief Executive Officer sold 15,000 shares at $3.16 ($47,343)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief Operating Officer bought 20,000 shares at an average $1.79 ($35,820)
  13. 4 Open-market buy Chief Financial Officer bought 13,000 shares at an average $1.68 ($21,839)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market sale Director sold 25,000 shares at an average $2.77 ($69,129)
  17. 4 Grant or award Director acquired 90,000 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Vice President bought 5,000 shares at an average $2.04 ($10,199)
  20. 4 Open-market sale Chief Executive Officer sold 315,000 shares at an average $2.09 ($658,277)

Page 13 of 16 · 317 filings